AAAAAA
Results:
1-8
|
Results: 8
Authors:
Spiera, RF
Mitnick, HJ
Kupersmith, M
Richmond, M
Spiera, H
Peterson, MGE
Paget, SA
Citation: Rf. Spiera et al., A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA), CLIN EXP RH, 19(5), 2001, pp. 495-501
Authors:
Spiera, RF
Paget, S
Spiera, H
Citation: Rf. Spiera et al., Methotrexate in giant-cell arteritis, ANN INT MED, 135(11), 2001, pp. 1006-1007
Authors:
Kerr, LD
Chang, YJ
Spiera, H
Fallon, JT
Citation: Ld. Kerr et al., Occult active giant cell aortitis necessitating surgical repair, J THOR SURG, 120(4), 2000, pp. 813-815
Authors:
Walker, RH
Spiera, H
Brin, MF
Olanow, CW
Citation: Rh. Walker et al., Parkinsonism associated with Sjogren's syndrome: Three cases and a review of the literature, MOVEMENT D, 14(2), 1999, pp. 262-268
Authors:
Chang, YJ
Spiera, H
Citation: Yj. Chang et H. Spiera, Renal transplantation in scleroderma, MEDICINE, 78(6), 1999, pp. 382-385
Authors:
Tan, FK
Arnett, FC
Antohi, S
Saito, S
Mirarchi, A
Spiera, H
Sasaki, T
Shoichi, O
Takeuchi, K
Pandy, JP
Silver, RM
LeRoy, C
Postlethwaite, AE
Bona, CA
Citation: Fk. Tan et al., Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases, J IMMUNOL, 163(2), 1999, pp. 1066-1072
Authors:
Kupersmith, MJ
Langer, R
Mitnick, H
Spiera, R
Spiera, H
Richmond, M
Paget, S
Citation: Mj. Kupersmith et al., Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy, BR J OPHTH, 83(7), 1999, pp. 796-801
Authors:
Naarendorp, M
Spiera, H
Citation: M. Naarendorp et H. Spiera, Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndrome and antiphospholipid antibodies - Drs. Naarendorp and Spiera reply, J RHEUMATOL, 25(12), 1998, pp. 2476-2477
Risultati:
1-8
|